论文信息 - Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively - 字舞流文

Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively

E. Clappier | H. Dombret | A. Plesa | C. Preudhomme | T. Cluzeau | L. Adès | C. Gardin | R. Itzykson | C. Berthon | T. Braun | C. Roumier | E. Raffoux | A. Puissant | K. Celli-Lebras | S. Mathis | D. Lebon | R. Dal Bello | Clémentine Chauvel | Kim Pacchiardi | E. Fournier | Justine Pasanisi | Elise Fournier | Stéphanie Mathis

[1] A. Letai,et al. Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations. , 2021, Cancer cell.

[2] H. Dombret,et al. Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy. , 2021, Blood.

[3] H. Dombret,et al. Genetic Identification of AML Patients Older than 60 years Achieving Long-term Survival with Intensive Chemotherapy. , 2021, Blood.

[4] J. Bourhis,et al. Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results. , 2020, Blood advances.

[5] Bob Löwenberg,et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. , 2017, Blood.

[6] W. Pierceall,et al. BH3 Profiling Discriminates Response to Cytarabine-Based Treatment of Acute Myelogenous Leukemia , 2013, Molecular Cancer Therapeutics.

[7] A. Letai,et al. Relative Mitochondrial Priming of Myeloblasts and Normal HSCs Determines Chemotherapeutic Success in AML , 2012, Cell.

[8] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .